Evidence
How we made the decision
How we made the decision
Exceptionally, significant new evidence may mean an update of a guideline is agreed before the next scheduled check of the need for updating. The evidence might be a single piece of evidence, an accumulation of evidence or other published NICE guidance.
For details of the process and update decisions that are available, see ensuring that published guidelines are current and accurate in 'Developing NICE guidelines: the manual'.
New evidence
We were notified of 1 new study which could impact on current guideline recommendations. The results of this study were considered in detail to determine an impact on guideline recommendations.
Views of topic experts
We considered the views of topic experts, including those who helped to develop the guideline.
Views of stakeholders
Stakeholders are consulted only if we decide not to update the guideline following checks at 4 and 8 years after publication. Because this was an exceptional surveillance review, and the decision was to update, we did not consult on the decision.
See ensuring that published guidelines are current and accurate in 'Developing NICE guidelines: the manual' for more details on our consultation processes.
NICE Surveillance programme project team
Sarah Willett
Associate Director
Philip Alderson
Consultant Clinical Adviser
Emma McFarlane
Technical Adviser
Katrina Sparrow
Technical Adviser
The NICE project team would like to thank the topic experts who participated in the surveillance process.
ISBN: 978-1-4731-2257-4
This page was last updated: